Sooryanarayana Varambally
Overview
Explore the profile of Sooryanarayana Varambally including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
18534
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karthikeyan S, Nallasamy P, Cleveland J, Arulmani A, Raveendran A, Karimi M, et al.
Redox Biol
. 2025 Feb;
81:103525.
PMID: 39986116
Proteotoxic stress progressively leads to irreversible cardiac abnormalities. Using a mouse model of reductive stress-induced proteotoxic cardiomyopathy, we identified novel microRNA signatures, termed "ProteotoxomiRs," which reflect stage-specific and transgene-specific responses...
2.
Varambally S, Karthikeyan S, Chandrashekar D, Sahai S, Shrestha S, Aneja R, et al.
Res Sq
. 2024 Oct;
PMID: 39399665
Breast cancer (BCa) is one of the most common malignancies among women worldwide. It is a complex disease that is characterized by morphological and molecular heterogeneity. In the early stages...
3.
Chandrashekar D, Afaq F, Karthikeyan S, Athar M, Shrestha S, Singh R, et al.
Neoplasia
. 2024 Sep;
57:101046.
PMID: 39241280
The bromodomain and extraterminal (BET) family of proteins show altered expression across various cancers. The members of the bromodomain (BRD) family contain epigenetic reader domains that bind to acetylated lysine...
4.
Wang X, Qiao Y, Asangani I, Ateeq B, Poliakov A, Cieslik M, et al.
Cancer Cell
. 2024 Aug;
42(8):1471.
PMID: 39137731
No abstract available.
5.
Mukherjee A, Cui J, Patel P, Bhagia P, McCammon S, Varambally S, et al.
Am J Otolaryngol
. 2024 Aug;
45(6):104444.
PMID: 39096566
Background: Solid organ transplant recipients have an elevated risk of cancer following organ transplantation than the age-adjusted general population. We assessed incidence of head and neck squamous cell carcinoma (HNSCC)...
6.
Bajpai P, Agarwal S, Afaq F, Al Diffalha S, Chandrashekar D, Kim H, et al.
J Exp Clin Cancer Res
. 2024 Jul;
43(1):192.
PMID: 38992681
Background: Treatment with regorafenib, a multiple-kinase inhibitor, to manage metastatic colorectal cancers (mCRCs) shows a modest improvement in overall survival but is associated with severe toxicities. Thus, to reduce regorafenib-induced...
7.
McKinney L, Singh R, Jordan I, Varambally S, Dammer E, Lillard Jr J
Onco (Basel)
. 2024 Mar;
3(2):81-95.
PMID: 38435029
Prostate cancer (PCa) is the second most common cause of cancer death in American men. Metastatic castration-resistant prostate cancer (mCRPC) is the most lethal form of PCa and preferentially metastasizes...
8.
Afaq F, Agarwal S, Bajpai P, Al Diffalha S, Kim H, Peter S, et al.
Neoplasia
. 2023 Dec;
47:100951.
PMID: 38039923
Thyroid hormone receptor-interacting protein 13 (TRIP13) is involved in cancer progression, but its role in pancreatic ductal adenocarcinoma (PDAC) is unknown. Thus, we assessed the expression, functional role, and mechanism...
9.
McFadden M, Singh S, Kinnel B, Varambally S, Singh R
J Ovarian Res
. 2023 Nov;
16(1):220.
PMID: 37990267
Background: High-grade serous ovarian cancer (OvCa) is the most common type of epithelial OvCa. It is usually diagnosed in advanced stages, leaving a woman's chance of survival below 50%. Despite...
10.
Parida P, Lewis S, Sharan K, Kamal M, Kumar N, Godkhindi V, et al.
Cells
. 2023 Nov;
12(21).
PMID: 37947608
, also known as URCL4, has been reported to have higher expression and be associated with poor prognosis in lung adenocarcinoma patients, and its role in regulation of the EGFR/AKT/mTORC1...